Hadasit Financial Statements From 2010 to 2025
| HSITFDelisted Stock | USD 0.12 0.00 0.00% |
Check Hadasit Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hadasit Bio's main balance sheet or income statement drivers, such as , as well as many indicators such as . Hadasit financial statements analysis is a perfect complement when working with Hadasit Bio Valuation or Volatility modules.
Hadasit |
Hadasit Bio Holdings Company Current Valuation Analysis
Hadasit Bio's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Hadasit Bio Current Valuation | (988.32 K) |
Most of Hadasit Bio's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hadasit Bio Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Hadasit Bio Holdings has a Current Valuation of (988,315). This is 100.01% lower than that of the Healthcare sector and 100.02% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 100.01% higher than that of the company.
Hadasit Bio Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hadasit Bio's current stock value. Our valuation model uses many indicators to compare Hadasit Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hadasit Bio competition to find correlations between indicators driving Hadasit Bio's intrinsic value. More Info.Hadasit Bio Holdings is one of the top stocks in return on equity category among its peers. It is rated # 4 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hadasit Bio's earnings, one of the primary drivers of an investment's value.About Hadasit Bio Financial Statements
Hadasit Bio stakeholders use historical fundamental indicators, such as Hadasit Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Hadasit Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Hadasit Bio's assets and liabilities are reflected in the revenues and expenses on Hadasit Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Hadasit Bio Holdings. Please read more on our technical analysis and fundamental analysis pages.
Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. Hadasit Bio-Holdings Ltd was founded in 2005 and is based in Jerusalem, Israel. Hadasit Bio is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Hadasit Pink Sheet
If you are still planning to invest in Hadasit Bio Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hadasit Bio's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance |